TY - JOUR
T1 - A case of Gitelman's syndrome with decreased angiotensin II - Forming activity
AU - Eto, Kimika
AU - Onaka, Uran
AU - Tsuchihashi, Takuya
AU - Hirano, Takashi
AU - Nakayama, Masaru
AU - Masutani, Kosuke
AU - Hirakata, Hideki
AU - Urata, Hidenori
AU - Yasujima, Minoru
PY - 2006/7
Y1 - 2006/7
N2 - Gitelman's syndrome (GS) is a variant of Bartter's syndrome (BS) characterized by hypokalemic alkalosis, hypomagnesemia, hypocalciuria and secondary aldosteronism without hypertension. A 31-year old Japanese man who had suffered from mild hypokalemia for 10 years was admitted to our hospital. He had metabolic alkalosis, hypokalemia and hypocalciuria. Since he had two missense mutations (R261C and L623P) in the thiazide-sensitive Na-CI cotransporter (TSC) gene (SLC12A3), he was diagnosed as having GS. He showed hyperreninism and a high angiotensin I (Ang I) level, whereas his angiotensin II (Ang II) and aldosterone levels were not elevated. His angiotensin converting enzyme (ACE) activities were normal, and administration of captopril inhibited the production of Ang II and aldosterone. We evaluated the Ang II-forming activity (AIIFA) of other enzymes in his lymphocytes. Interestingly, chymase-dependent AIIFA was not detected in the lymphocytes. Together, these results suggest that the lack of chymase activity resulted in the manifestation of GS without hyperaldosteronism.
AB - Gitelman's syndrome (GS) is a variant of Bartter's syndrome (BS) characterized by hypokalemic alkalosis, hypomagnesemia, hypocalciuria and secondary aldosteronism without hypertension. A 31-year old Japanese man who had suffered from mild hypokalemia for 10 years was admitted to our hospital. He had metabolic alkalosis, hypokalemia and hypocalciuria. Since he had two missense mutations (R261C and L623P) in the thiazide-sensitive Na-CI cotransporter (TSC) gene (SLC12A3), he was diagnosed as having GS. He showed hyperreninism and a high angiotensin I (Ang I) level, whereas his angiotensin II (Ang II) and aldosterone levels were not elevated. His angiotensin converting enzyme (ACE) activities were normal, and administration of captopril inhibited the production of Ang II and aldosterone. We evaluated the Ang II-forming activity (AIIFA) of other enzymes in his lymphocytes. Interestingly, chymase-dependent AIIFA was not detected in the lymphocytes. Together, these results suggest that the lack of chymase activity resulted in the manifestation of GS without hyperaldosteronism.
UR - http://www.scopus.com/inward/record.url?scp=33748543558&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33748543558&partnerID=8YFLogxK
U2 - 10.1291/hypres.29.545
DO - 10.1291/hypres.29.545
M3 - Article
C2 - 17044667
AN - SCOPUS:33748543558
SN - 0916-9636
VL - 29
SP - 545
EP - 549
JO - Hypertension Research
JF - Hypertension Research
IS - 7
ER -